XBIOTECH INC. Current Liabilities
XBIOTECH INC. (XBIT) had Current Liabilities of $3.35 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Liabilities, Current $3.35M.
- 2026-03-31: Liabilities, Current $3.00M.
- 2025-12-31: Liabilities, Current $7.93M.
- 2025-09-30: Liabilities, Current $3.56M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $3.35M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $3.00M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $7.93M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $3.56M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $3.86M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $5.41M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $15.11M 10-K · filed 2026-03-13 |
| 2024-09-30 | $15.99M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $17.14M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $16.88M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $6.10M 10-K · filed 2025-03-18 |
| 2023-09-30 | $5.29M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $4.45M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $3.62M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $4.07M 10-K · filed 2024-03-15 |
| 2022-09-30 | $3.58M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $8.23M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $2.89M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $3.45M 10-K · filed 2023-03-15 |
| 2021-09-30 | $3.86M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $3.89M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $2.72M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $3.98M 10-K · filed 2022-03-15 |
| 2020-09-30 | $6.20M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $14.14M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $10.23M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $60.19M 10-K · filed 2021-03-16 |
| 2019-09-30 | $2.02M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $2.46M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $2.84M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $2.94M 10-K · filed 2020-03-16 |
| 2018-09-30 | $2.30M 10-Q · filed 2018-10-31 |
| 2018-06-30 | $2.76M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $2.43M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $2.79M 10-K/A · filed 2019-03-15 |
| 2017-09-30 | $3.50M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $4.66M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $5.32M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $7.96M 10-K · filed 2018-03-16 |
| 2016-09-30 | $6.64M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $10.38M 10-Q · filed 2016-08-12 |
| 2016-03-31 | $6.56M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $6.29M 10-K · filed 2017-03-16 |
| 2015-09-30 | $4.96M 10-Q · filed 2015-11-13 |
| 2015-06-30 | $2.87M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $3.83M 10-Q · filed 2015-06-18 |
| 2014-12-31 | $3.15M 10-K · filed 2016-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |